Labcorp Holdings Inc. vs Eli Lilly & Co.
LH vs LLY — side-by-side comparison from reported financials. LH leads 3, LLY leads 9 of 12 comparable metrics.
Labcorp Holdings Inc.
LH · Healthcare
$311.84-0.75%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | LH | LLY |
|---|---|---|
| Price | $311.84 | $1 177.20 |
| Market cap | $25.3B | $1.05T |
| Revenue (TTM) | $14.3B | $79.7B |
| Revenue growth | +5.5% | +31.7% |
| Net margin | 7.0% | 33.5% |
| Free cash flow | $1.16B | $18.2B |
| Net cash (debt) | ($4.55B) | ($35.2B) |
| 1-year price return | +12.3% | +37.6% |
| P/E | 25.3 | 41.6 |
| P/E vs own history (cheap-side %) | 51% | 88% |
| Dividend yield | 0.94% | 0.52% |
| Return on equity | 12% | 93% |
| Altman Z-score | 2.86 | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 71,000 | 50,000 |
Full résumé-style profiles: LH CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.